Please enable JavaScript to continue using this application.

Compare $BCAX vs $VOR | Chartloom

Compare

$BCAX vs $VOR

Bicara Therapeutics Inc · Vor Biopharma Inc

BCAX

Bicara Therapeutics Inc

VOR

Vor Biopharma Inc

Compare $BCAX vs $VOR

Comparing Bicara Therapeutics Inc and Vor Biopharma Inc

BCAXBicara Therapeutics Inc

VORVor Biopharma Inc

BCAXBicara Therapeutics Inc

Market cap

$1.15B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.8%

52W performance

-2.8%

FCF yield

-11.8%

VORVor Biopharma Inc

Market cap

$1.08B

P/E (TTM)

1.72x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

71.0%

52W performance

-40.4%

FCF yield

-13.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAX

VOR

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

VOR

Vor Biopharma Inc

Market Cap

BCAX$1.15B

VOR$1.08B

Enterprise Value

BCAX$1.05B

VOR$971M

Price

BCAX$17.50

VOR$19.90

P/E Ratio

BCAXN/A

VOR1.72x

P/S Ratio

BCAX0.00x

VOR0.00x

EV/Sales

BCAX0.00x

VOR0.00x

EV/EBITDA

BCAX0.00x

VOR0.00x

P/B Ratio

BCAX2.49x

VOR16.48x

P/FCF Ratio

BCAXN/A

VORN/A

EV/FCF

BCAX-7.79x

VOR-6.89x

PEG Ratio

BCAXN/A

VORN/A

Forward P/E (NTM)

BCAXN/A

VORN/A

Forward P/S (NTM)

BCAXN/A

VORN/A

Revenue (TTM)

BCAX$0

VOR$0

Revenue Growth (YoY)

BCAXN/A

VORN/A

Forward Rev Growth

BCAX1358.6%

VOR488.1%

Gross Margin (TTM)

BCAX0.0%

VOR0.0%

Operating Margin (TTM)

BCAX0.0%

VOR0.0%

EBITDA Margin (TTM)

BCAX0.0%

VOR0.0%

Net Margin (TTM)

BCAX0.0%

VOR0.0%

FCF Margin (TTM)

BCAXN/A

VORN/A

Net Income (TTM)

BCAX$-185M

VOR$628M

FCF (TTM)

BCAX$-135M

VOR$-141M

EPS (TTM)

BCAX-$2.73

VOR$11.56

ROE (TTM)

BCAX-4149.0%

VOR-14213.0%

ROA (TTM)

BCAX-3859.0%

VOR154.2%

ROIC (TTM)

BCAX-4149.0%

VOR-14213.0%

Cash

BCAX$97M

VOR$108M

Debt

BCAX$0

VOR$0

Net Cash/Debt

BCAX$97M

VOR$108M

Current Ratio (TTM)

BCAX11.59x

VOR19.15x

Quick Ratio (TTM)

BCAX11.44x

VOR18.91x

Debt/Equity (TTM)

BCAX0.00x

VOR0.00x

Debt/Assets (TTM)

BCAX0.0%

VOR0.0%

Interest Coverage (TTM)

BCAXN/A

VORN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

VOR0.00x

Beta

BCAX0.94

VOR1.70

52W Performance

BCAX-2.8%

VOR-40.4%

YTD Performance

BCAX6.8%

VOR71.0%

% from 52W High

BCAX-43.5%

VOR-40.6%

% from 52W Low

BCAX27.7%

VOR206.2%

Asset Turnover (TTM)

BCAX0.00x

VOR0.00x

FCF Yield (TTM)

BCAX-11.8%

VOR-13.1%

Earnings Yield (TTM)

BCAX-16.1%

VOR58.2%

Dividend Yield (TTM)

BCAXN/A

VORN/A

Rule of 40

BCAX0.0

VOR0.0

EV/GP/RG

BCAXN/A

VORN/A

Ticker research

View BCAX research View VOR research

Metric	BCAX Bicara Therapeutics Inc	VOR Vor Biopharma Inc
Market & Valuation
Market Cap	$1.15B	$1.08B
Enterprise Value	$1.05B	$971M
Price	$17.50	$19.90
P/E Ratio	N/A	1.72x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	16.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-6.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	488.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$628M
FCF (TTM)	$-135M	$-141M
EPS (TTM)	-$2.73	$11.56
ROE (TTM)	-4149.0%	-14213.0%
ROA (TTM)	-3859.0%	154.2%
ROIC (TTM)	-4149.0%	-14213.0%
Financial Health
Cash	$97M	$108M
Debt	$0	$0
Net Cash/Debt	$97M	$108M
Current Ratio (TTM)	11.59x	19.15x
Quick Ratio (TTM)	11.44x	18.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	1.70
52W Performance	-2.8%	-40.4%
YTD Performance	6.8%	71.0%
% from 52W High	-43.5%	-40.6%
% from 52W Low	27.7%	206.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	-13.1%
Earnings Yield (TTM)	-16.1%	58.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View VOR research

Valuation

P/E Ratio

VOR

1.72x

P/S Ratio

BCAX

0.00x

VOR

0.00x

EV/FCF

BCAX

-7.79x

VOR

-6.89x

Growth & revenue

Forward Revenue Growth

BCAX

1358.6%

VOR

488.1%

Profitability & performance

Gross Margin

BCAX

0.0%

VOR

0.0%

ROE

BCAX

-4149.0%

VOR

-14213.0%

FCF Yield %

BCAX

-11.8%

VOR

-13.1%

52-Week Performance

BCAX

-2.8%

VOR

-40.4%

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

VOR

Vor Biopharma Inc

Market Cap

BCAX$1.15B

VOR$1.08B

Enterprise Value

BCAX$1.05B

VOR$971M

Price

BCAX$17.50

VOR$19.90

P/E Ratio

BCAXN/A

VOR1.72x

P/S Ratio

BCAX0.00x

VOR0.00x

EV/Sales

BCAX0.00x

VOR0.00x

EV/EBITDA

BCAX0.00x

VOR0.00x

P/B Ratio

BCAX2.49x

VOR16.48x

P/FCF Ratio

BCAXN/A

VORN/A

EV/FCF

BCAX-7.79x

VOR-6.89x

PEG Ratio

BCAXN/A

VORN/A

Forward P/E (NTM)

BCAXN/A

VORN/A

Forward P/S (NTM)

BCAXN/A

VORN/A

Revenue (TTM)

BCAX$0

VOR$0

Revenue Growth (YoY)

BCAXN/A

VORN/A

Forward Rev Growth

BCAX1358.6%

VOR488.1%

Gross Margin (TTM)

BCAX0.0%

VOR0.0%

Operating Margin (TTM)

BCAX0.0%

VOR0.0%

EBITDA Margin (TTM)

BCAX0.0%

VOR0.0%

Net Margin (TTM)

BCAX0.0%

VOR0.0%

FCF Margin (TTM)

BCAXN/A

VORN/A

Net Income (TTM)

BCAX$-185M

VOR$628M

FCF (TTM)

BCAX$-135M

VOR$-141M

EPS (TTM)

BCAX-$2.73

VOR$11.56

ROE (TTM)

BCAX-4149.0%

VOR-14213.0%

ROA (TTM)

BCAX-3859.0%

VOR154.2%

ROIC (TTM)

BCAX-4149.0%

VOR-14213.0%

Cash

BCAX$97M

VOR$108M

Debt

BCAX$0

VOR$0

Net Cash/Debt

BCAX$97M

VOR$108M

Current Ratio (TTM)

BCAX11.59x

VOR19.15x

Quick Ratio (TTM)

BCAX11.44x

VOR18.91x

Debt/Equity (TTM)

BCAX0.00x

VOR0.00x

Debt/Assets (TTM)

BCAX0.0%

VOR0.0%

Interest Coverage (TTM)

BCAXN/A

VORN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

VOR0.00x

Beta

BCAX0.94

VOR1.70

52W Performance

BCAX-2.8%

VOR-40.4%

YTD Performance

BCAX6.8%

VOR71.0%

% from 52W High

BCAX-43.5%

VOR-40.6%

% from 52W Low

BCAX27.7%

VOR206.2%

Asset Turnover (TTM)

BCAX0.00x

VOR0.00x

FCF Yield (TTM)

BCAX-11.8%

VOR-13.1%

Earnings Yield (TTM)

BCAX-16.1%

VOR58.2%

Dividend Yield (TTM)

BCAXN/A

VORN/A

Rule of 40

BCAX0.0

VOR0.0

EV/GP/RG

BCAXN/A

VORN/A

Ticker research

View BCAX research View VOR research

Metric	BCAX Bicara Therapeutics Inc	VOR Vor Biopharma Inc
Market & Valuation
Market Cap	$1.15B	$1.08B
Enterprise Value	$1.05B	$971M
Price	$17.50	$19.90
P/E Ratio	N/A	1.72x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	16.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-6.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	488.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$628M
FCF (TTM)	$-135M	$-141M
EPS (TTM)	-$2.73	$11.56
ROE (TTM)	-4149.0%	-14213.0%
ROA (TTM)	-3859.0%	154.2%
ROIC (TTM)	-4149.0%	-14213.0%
Financial Health
Cash	$97M	$108M
Debt	$0	$0
Net Cash/Debt	$97M	$108M
Current Ratio (TTM)	11.59x	19.15x
Quick Ratio (TTM)	11.44x	18.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	1.70
52W Performance	-2.8%	-40.4%
YTD Performance	6.8%	71.0%
% from 52W High	-43.5%	-40.6%
% from 52W Low	27.7%	206.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	-13.1%
Earnings Yield (TTM)	-16.1%	58.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View VOR research